Literature DB >> 19620341

Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model.

Philana Ling Lin1, Mark Rodgers, Le'kneitah Smith, Matthew Bigbee, Amy Myers, Carolyn Bigbee, Ion Chiosea, Saverio V Capuano, Carl Fuhrman, Edwin Klein, JoAnne L Flynn.   

Abstract

We previously described that low-dose Mycobacterium tuberculosis infection in cynomolgus macaques results in a spectrum of disease similar to that of human infection: primary disease, latent infection, and reactivation tuberculosis (S. V. Capuano III, D. A. Croix, S. Pawar, A. Zinovik, A. Myers, P. L. Lin, S. Bissel, C. Fuhrman, E. Klein, and J. L. Flynn, Infect. Immun. 71:5831-5844, 2003). This is the only established model of latent infection, and it provides a unique opportunity to understand host and pathogen differences across of range of disease states. Here, we provide a more extensive and detailed characterization of the gross pathology, microscopic histopathology, and immunologic characteristics of monkeys in each clinical disease category. The data underscore the similarities between human and nonhuman primate M. tuberculosis infection. Furthermore, we describe novel methods of quantifying gross pathology and bacterial burden that distinguish between active disease and latent infection, and we extend the usefulness of this model for comparative studies. Early in infection, an abnormal chest X ray, M. tuberculosis growth by gastric aspirate, and increased mycobacterium-specific gamma interferon (IFN-gamma) in peripheral blood mononuclear cells (PBMCs) and bronchoalveolar lavage (BAL) cells were associated with the development of active disease. At necropsy, disease was quantified with respect to pathology and bacterial numbers. Microscopically, a spectrum of granuloma types are seen and differ with disease type. At necropsy, monkeys with active disease had more lung T cells and more IFN-gamma from PBMC, BAL, and mediastinal lymph nodes than monkeys with latent infection. Finally, we have observed a spectrum of disease not only in monkeys with active disease but also in those with latent infection that provides insight into human latent tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19620341      PMCID: PMC2747916          DOI: 10.1128/IAI.00592-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model.

Authors:  Yoko Kita; Takao Tanaka; Shigeto Yoshida; Naoya Ohara; Yasufumi Kaneda; Sachiko Kuwayama; Yumiko Muraki; Noriko Kanamaru; Satomi Hashimoto; Hiroko Takai; Chika Okada; Yukari Fukunaga; Yayoi Sakaguchi; Izumi Furukawa; Kyoko Yamada; Yoshikazu Inoue; Yuji Takemoto; Mariko Naito; Takeshi Yamada; Makoto Matsumoto; David N McMurray; E C Dela Cruz; E V Tan; R M Abalos; J A Burgos; Robert Gelber; Yasir Skeiky; Steven Reed; Mitsunori Sakatani; Masaji Okada
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

2.  Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection.

Authors:  J Y Lee; H J Choi; I-N Park; S-B Hong; Y-M Oh; C-M Lim; S D Lee; Y Koh; W S Kim; D S Kim; W D Kim; T S Shim
Journal:  Eur Respir J       Date:  2006-04-12       Impact factor: 16.671

3.  Early events in Mycobacterium tuberculosis infection in cynomolgus macaques.

Authors:  Philana Ling Lin; Santosh Pawar; Amy Myers; Amarenda Pegu; Carl Fuhrman; Todd A Reinhart; Saverio V Capuano; Edwin Klein; Joanne L Flynn
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis.

Authors:  Pernille Ravn; Martin E Munk; Ase B Andersen; Bettina Lundgren; Jens D Lundgren; Lars N Nielsen; Axel Kok-Jensen; Peter Andersen; Karin Weldingh
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

5.  Pulmonary tuberculosis: comparison of CT findings in HIV-seropositive and HIV-seronegative patients.

Authors:  A N Leung; M W Brauner; G Gamsu; N Mlika-Cabanne; H Ben Romdhane; M F Carette; P Grenier
Journal:  Radiology       Date:  1996-03       Impact factor: 11.105

6.  Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay.

Authors:  Delia Goletti; Donatella Vincenti; Stefania Carrara; Ornella Butera; Federica Bizzoni; Giuliana Bernardini; Massimo Amicosante; Enrico Girardi
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

7.  Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6.

Authors:  Jan A M Langermans; T Mark Doherty; Richard A W Vervenne; Tridia van der Laan; Konstantin Lyashchenko; Rena Greenwald; Else Marie Agger; Claus Aagaard; Horst Weiler; Dick van Soolingen; Wilfried Dalemans; Alan W Thomas; Peter Andersen
Journal:  Vaccine       Date:  2005-04-15       Impact factor: 3.641

8.  Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study.

Authors:  D Goletti; S Carrara; D Vincenti; C Saltini; E Busi Rizzi; V Schininà; G Ippolito; M Amicosante; E Girardi
Journal:  Clin Microbiol Infect       Date:  2006-06       Impact factor: 8.067

9.  The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease.

Authors:  G P Walsh; E V Tan; E C dela Cruz; R M Abalos; L G Villahermosa; L J Young; R V Cellona; J B Nazareno; M A Horwitz
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

10.  Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis.

Authors:  J-P Janssens; P Roux-Lombard; T Perneger; M Metzger; R Vivien; T Rochat
Journal:  Eur Respir J       Date:  2007-05-30       Impact factor: 16.671

View more
  203 in total

1.  Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection.

Authors:  Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; JoAnne L Flynn; Denise E Kirschner
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  CD4 T cell depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent infection is dependent on severity of tissue depletion in cynomolgus macaques.

Authors:  Philana Ling Lin; Tara Rutledge; Angela M Green; Matthew Bigbee; Carl Fuhrman; Edwin Klein; JoAnne L Flynn
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-04       Impact factor: 2.205

3.  Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model.

Authors:  Philana Ling Lin; Amy Myers; Le'Kneitah Smith; Carolyn Bigbee; Matthew Bigbee; Carl Fuhrman; Heather Grieser; Ion Chiosea; Nikolai N Voitenek; Saverio V Capuano; Edwin Klein; JoAnne L Flynn
Journal:  Arthritis Rheum       Date:  2010-02

4.  From the mouths of monkeys: detection of Mycobacterium tuberculosis complex DNA from buccal swabs of synanthropic macaques.

Authors:  Alicia K Wilbur; Gregory A Engel; Aida Rompis; I G A A Putra; Benjamin P Y-H Lee; Nantiya Aggimarangsee; Mukesh Chalise; Eric Shaw; Gunwha Oh; Michael A Schillaci; Lisa Jones-Engel
Journal:  Am J Primatol       Date:  2012-07       Impact factor: 2.371

5.  Noninvasive Tuberculosis Screening in Free-Living Primate Populations in Gombe National Park, Tanzania.

Authors:  Tiffany M Wolf; Srinand Sreevatsan; Randall S Singer; Iddi Lipende; Anthony Collins; Thomas R Gillespie; Elizabeth V Lonsdorf; Dominic A Travis
Journal:  Ecohealth       Date:  2015-09-29       Impact factor: 3.184

6.  Pulmonary Mycobacterium tuberculosis control associates with CXCR3- and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment.

Authors:  Uma Shanmugasundaram; Allison N Bucsan; Shashank R Ganatra; Chris Ibegbu; Melanie Quezada; Robert V Blair; Xavier Alvarez; Vijayakumar Velu; Deepak Kaushal; Jyothi Rengarajan
Journal:  JCI Insight       Date:  2020-07-23

7.  A hydrolase of trehalose dimycolate induces nutrient influx and stress sensitivity to balance intracellular growth of Mycobacterium tuberculosis.

Authors:  Yong Yang; Kathleen Kulka; Ronald C Montelaro; Todd A Reinhart; James Sissons; Alan Aderem; Anil K Ojha
Journal:  Cell Host Microbe       Date:  2014-02-12       Impact factor: 21.023

8.  A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment.

Authors:  Elsje Pienaar; Nicholas A Cilfone; Philana Ling Lin; Véronique Dartois; Joshua T Mattila; J Russell Butler; JoAnne L Flynn; Denise E Kirschner; Jennifer J Linderman
Journal:  J Theor Biol       Date:  2014-12-09       Impact factor: 2.691

Review 9.  CD8 T cells and Mycobacterium tuberculosis infection.

Authors:  Philana Ling Lin; JoAnne L Flynn
Journal:  Semin Immunopathol       Date:  2015-04-28       Impact factor: 9.623

Review 10.  Antibody-mediated immunity against tuberculosis: implications for vaccine development.

Authors:  Jacqueline M Achkar; Arturo Casadevall
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.